Genexine
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 10/29/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (27)
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Started: 1/25/2024
Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines
Started: 10/1/2021
Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency
Started: 1/18/2016
Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
Started: 4/15/2014
A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9
Started: 1/1/2015
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Started: 7/1/2014
Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer
Started: 3/1/2014
Clinical Trial of Efepoetin Alfa in Healthy Subjects
Started: 10/29/2024
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
Started: 12/30/2020
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
Started: 6/17/2020
The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer
Started: 6/19/2018
Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)
Started: 3/27/2019
Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals
Started: 2/16/2021
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19
Started: 3/24/2021
Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
Started: 8/22/2019
Safety and Tolerability of GX-P1 in Healthy Male Volunteers
Started: 8/11/2020
Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
Started: 6/20/2018
Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients
Started: 9/7/2017
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors
Started: 10/17/2018
Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors
Started: 3/5/2018
Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers
Started: 2/16/2017
Safety and Tolerability of GX-G6 in Healthy Male Subjects
Started: 8/31/2017
Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects
Started: 11/1/2014
Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3
Started: 11/1/2012
Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients
Started: 11/1/2011